blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2204380

EP2204380 - hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.07.2011
Database last updated on 26.06.2024
Most recent event   Tooltip01.07.2011Application deemed to be withdrawnpublished on 03.08.2011  [2011/31]
Applicant(s)For all designated states
Charité - Universitätsmedizin Berlin
Charitéplatz 1
10117 Berlin / DE
[2010/27]
Inventor(s)01 / Skriner, Karl
Kirchstrasse 19
10557 Berlin / DE
02 / Adolph, Kerstin
Bambergerstrasse 53
10777 Berlin / DE
03 / Hollidt, Jörg
Dammsmühler Strasse 49c
13158 Berlin / DE
 [2010/27]
Representative(s)Gulde & Partner
Patent- und Rechtsanwaltskanzlei mbB
Wallstrasse 58/59
10179 Berlin / DE
[N/P]
Former [2010/27]Gulde Hengelhaupt Ziebig & Schneider
Patentanwälte - Rechtsanwälte Wallstrasse 58/59
10179 Berlin / DE
Application number, filing date08172809.923.12.2008
[2010/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2204380
Date:07.07.2010
Language:EN
[2010/27]
Search report(s)(Supplementary) European search report - dispatched on:EP06.04.2009
ClassificationIPC:C07K14/43, C12N15/11
[2010/27]
CPC:
C07K14/47 (EP,US); C07K7/08 (EP,US)
Designated contracting states(deleted) [2011/11]
Former [2010/27]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:hnRNP-A3-verwandte Peptide und deren Verwendung zur Diagnose von rheumatoider Arthritis[2010/27]
English:hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis[2010/27]
French:Peptides de type hnRNP A3 et leur utilisation pour le diagnostic de l'arthrite rhumatoïde[2010/27]
Examination procedure08.01.2011Application deemed to be withdrawn, date of legal effect  [2011/31]
15.02.2011Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2011/31]
Fees paidPenalty fee
Additional fee for renewal fee
31.12.201003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9814469  (US HEALTH [US], et al) [X] 1 * page 11; claim 4 *;
 [X]US2003068803  (REED ROBIN [US], et al) [X] 3 * claim 24 *
 [Y]  - HAYER SILVIA ET AL, "Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice", JOURNAL OF IMMUNOLOGY, (200512), vol. 175, no. 12, ISSN 0022-1767, pages 8327 - 8336, XP002518173 [Y] 1-13 * Abstract and Results *
 [X]  - SIAPKA SORANA ET AL, "Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen", AUTOIMMUNITY, HARWOOD, CHUR, CH, (20070501), vol. 40, no. 3, ISSN 0891-6934, pages 223 - 233, XP009113371 [X] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1080/08916930701352357
 [Y]  - SUELEYMANOGLU, E., "Circular Dichroism and Fluorescence Spectroscopic Study of RNA-protein Folding Patterns in Human hnRNP A3 and Their Implications in Human Autoimmune Diseases", PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS [PROG. BIOCHEM. BIOPHYS.], (20040300) VOL. 31, NO. 3, PP. 219-224. ISSN: 1000-3282., (2004), vol. 31, no. 3, XP002518174 [Y] 1-13 * the whole document *
 [A]  - STEINER G ET AL, "[Novel autoantibodies for the diagnosis of rheumatoid arthritis]", ZEITSCHRIFT FÜR RHEUMATOLOGIE DEC 2002, (200212), vol. 61, no. 6, ISSN 0340-1855, pages 667 - 673, XP002518175 [A] * page 669, column L, paragraph 1 - page 670, column R, paragraph LAST *

DOI:   http://dx.doi.org/10.1007/S00393-002-0470-Y
by applicantWO2007000320
    - YOUNG, B.J.J. ET AL., "Antikeratin antibodies in rheumatoid arthritis", B.M.J., (1979), vol. 2, pages 97 - 99
    - VINCENT, C.H. ET AL., "High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called "antikeratin antibodies", ANN. RHEUMAT. DIS., (1989), vol. 48, pages 712 - 722
    - VINCENT, C.H. ET AL., "Natural IgG to Epidermal Cytokeratins vs IgG to the Stratum Corneum of the Rat Oesophagus Epithelium, so-called "Antikeratin Antibodies", in Rheumatoid Arthritis and other Rheumatic Diseases", J. OF AUTOIMMUNITY, (1991), vol. 4, doi:doi:10.1016/0896-8411(91)90161-5, pages 493 - 505, XP026263798

DOI:   http://dx.doi.org/10.1016/0896-8411(91)90161-5
    - F'AIMELA, L. ET AL., "Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid Arthritis", ANN. RHEUMAT. DIS., (1992), vol. 51, pages 743 - 746
    - SIMON, M. ET AL., "The Cytokeratin Filament-Aggregating Protein Filaggrin is the Target of the So-called "Antikeratin Antibodies", Autoantibodies Specific for Rheumatoid Arthritis", J. CLIN. INVEST., (1993), vol. 92, pages 1387 - 93
    - CHOREV ET AL., TRENDS BIOTECH., (1995), vol. 13, pages 438 - 445
    - GREGORIUS, K.; MOURITSEN, S.; ELSNER, H.I., "Hydrocoating: a new method for coupling biomolecules to solid phases", J.IMMUNOL. METHODS, (1995), vol. 12, doi:doi:10.1016/0022-1759(94)00330-Y, pages 65 - 73, XP004021057

DOI:   http://dx.doi.org/10.1016/0022-1759(94)00330-Y
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.